| Date Filed | Type | Description |
| 10/06/2023 |
4
| Romano Sarah (CFO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Sold 1,676 shares
@ $0.29, valued at
$486 |
|
| 10/06/2023 |
4
| SAPIRSTEIN JAMES (President and CEO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Sold 2,764 shares
@ $0.29, valued at
$801.6 |
|
| 07/05/2023 |
4
| Romano Sarah (CFO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Sold 1,977 shares
@ $1.54, valued at
$3k
|
|
| 07/05/2023 |
4
| SAPIRSTEIN JAMES (President and CEO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Sold 3,349 shares
@ $1.54, valued at
$5.2k
|
|
| 04/05/2023 |
4
| Romano Sarah (CFO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Sold 1,975 shares
@ $2.5, valued at
$4.9k
|
|
| 04/05/2023 |
4
| SAPIRSTEIN JAMES (President and CEO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Sold 3,347 shares
@ $2.5, valued at
$8.4k
|
|
| 01/05/2023 |
4
| Coelho Mary Theresa (Director) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 84,745 shares
@ $0 |
|
| 01/05/2023 |
4
| Romano Sarah (CFO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 150,000 shares
@ $0 |
|
| 01/05/2023 |
4
| SAPIRSTEIN JAMES (President and CEO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 300,000 shares
@ $0 |
|
| 01/05/2023 |
4
| BORKOWSKI EDWARD (Director) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 84,745 shares
@ $0 |
|
| 01/05/2023 |
4
| Hoffman David Andrew (Director) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 84,745 shares
@ $0 |
|
| 01/05/2023 |
4
| CASAMENTO CHARLES J (Director) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 84,745 shares
@ $0 |
|
| 01/05/2023 |
4
| Riddell Alastair (Director) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 84,745 shares
@ $0 |
|
| 05/04/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/02/2022 |
4
| Romano Sarah (CFO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.18, valued at
$177k
|
|
| 03/02/2022 |
3
| Romano Sarah (CFO) has filed a Form 3 on First Wave BioPharma, Inc. |
| 01/03/2022 |
4
| CASAMENTO CHARLES J (Director) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 34,482 options to buy
@ $1.45, valued at
$50k
|
|
| 01/03/2022 |
4
| Riddell Alastair (Director) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 34,482 options to buy
@ $1.45, valued at
$50k
|
|
| 01/03/2022 |
4
| Coelho Mary Theresa (Director) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 34,482 options to buy
@ $1.45, valued at
$50k
|
|
| 01/03/2022 |
4
| BORKOWSKI EDWARD (Director) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 34,482 options to buy
@ $1.45, valued at
$50k
|
|
| 01/03/2022 |
4
| SAPIRSTEIN JAMES (PRES, CEO & CHAIRMAN OF BOARD) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.45, valued at
$217.5k
|
|
| 01/03/2022 |
4
| Pennington James (CHIEF MEDICAL OFFICER) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 7,500 options to buy
@ $1.45, valued at
$10.9k
|
|
| 01/03/2022 |
4
| Oakes Gregory (Director) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 34,482 options to buy
@ $1.45, valued at
$50k
|
|
| 01/03/2022 |
4
| Schneiderman Daniel H (CFO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 10,000 options to buy
@ $1.45, valued at
$14.5k
|
|
| 01/03/2022 |
4
| Schramm Vern Lee (Director) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 34,482 options to buy
@ $1.45, valued at
$50k
|
|
| 09/13/2021 |
4
| Coelho Mary Theresa (Director) has filed a Form 4 on AzurRx BioPharma, Inc.|
Txns:
| Granted 10,310 options to buy
@ $0.64, valued at
$6.6k
|
|
| 08/17/2021 |
3
| Coelho Mary Theresa (Director) has filed a Form 3 on AzurRx BioPharma, Inc. |
| 07/09/2021 |
4
| Pennington James (CHIEF MEDICAL OFFICER) has filed a Form 4 on AzurRx BioPharma, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.75, valued at
$75k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Oakes Gregory (Director) has filed a Form 4 on AzurRx BioPharma, Inc.|
Txns:
| Granted 41,237 options to buy
@ $0.97, valued at
$40k
|
|
| 01/06/2021 |
4
| Schramm Vern Lee (Director) has filed a Form 4 on AzurRx BioPharma, Inc.|
Txns:
| Granted 41,237 options to buy
@ $0.97, valued at
$40k
|
|
| 01/06/2021 |
4
| Riddell Alastair (Director) has filed a Form 4 on AzurRx BioPharma, Inc.|
Txns:
| Granted 41,237 options to buy
@ $0.97, valued at
$40k
|
|
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|